Rare diseases
Investigational molecules
Locations
Back to Poland337 clinical trials in Rzeszow, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
PolandStudy of Elafibranor for Adults with Primary Biliary Cholangitis
PolandStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
PolandStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
PolandStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
PolandStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals
PolandStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandPharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis
PolandEfficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration
PolandPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
PolandEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focusing on innovative treatments for inflammatory bowel diseases and autoimmune conditions, including studies on new therapies for ulcerative colitis and Crohn's disease.
Multiple trials evaluating novel compounds and biological therapies for inflammatory conditions.
Studies investigating treatments for heart failure prevention and metabolic disorders, with emphasis on innovative therapeutic approaches for obesity and cardiovascular health.
Focus on combination therapies and novel compounds for cardiometabolic conditions.
Clinical investigations targeting multiple sclerosis and chronic inflammatory conditions affecting the nervous system.
Evaluation of new therapeutic agents for managing neurological and immune-mediated conditions.
Research on various specialized conditions including geographic atrophy and reproductive health treatments.
Diverse studies focusing on improving patient outcomes across multiple therapeutic areas.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
